サイバーナイフ市場 - 世界の産業規模、シェア、動向、機会、予測、用途別、最終用途別、地域別、競合別、2019～2029年

世界のサイバーナイフ市場は、2023年に4億4,824万米ドルとなり、2029年までのCAGRは17.28%で、予測期間には目覚ましい成長が予測されています。

世界のサイバーナイフ市場は、Accuray Incorporatedが開発した画期的な医療技術であるサイバーナイフシステムを中心に展開されています。このシステムは、高度なロボット工学、リアルタイムの画像処理、正確な放射線照射を統合し、腫瘍や病状を比類のない精度で治療します。従来の手術に代わる非侵襲的な治療法を提供するサイバーナイフ・システムは、切開せずに全身の腫瘍や病変を治療します。高度に操縦可能なロボットアームを利用し、健康な組織を温存しながら、ミリメートル以下の精度で複数の角度から高線量の放射線を照射します。リアルタイム画像処理により腫瘍の位置を追跡し、治療中の患者の動きにも対応しながら放射線の照射を調整します。同市場は、課題となっている部位であっても幅広いがんの治療に有効であることなど、いくつかの要因によって成長を遂げています。

非侵襲的な治療のため、患者の回復時間が短縮され、生活の質が向上します。継続的な研究開発努力により、サイバーナイフ技術は絶えず改良され、応用範囲が広がっています。サイバーナイフ技術の普及が進むにつれ、その精密さ、患者への優しさ、効率性により、がん治療に革命をもたらしています。高い調達コストやメンテナンスコスト、専門的なヘルスケア専門家のトレーニングの必要性といった課題にもかかわらず、世界のサイバーナイフ市場は前進しています。サイバーナイフは、患者の幸福と治療精度を優先した高度ながん治療オプションに対する需要の増加に対応しています。

主要な市場促進要因

精度と正確さ

非侵襲的治療

イメージングとロボティクスの進歩

がんの有病率の増加

主要な市場課題

高額な初期費用

保守・運用コスト

主要な市場動向

個別化治療

集学的治療との統合

セグメント別の洞察

用途別の洞察

地域別の洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 サイバーナイフの世界市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 用途別（腫瘍、がん、血管奇形、その他）
  • 最終用途別（病院、外来施設、研究・製造）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2023年）
• 製品市場マップ
  • 用途別
  • 最終用途別
  • 地域別

第6章 北米のサイバーナイフ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 用途別
  • 最終用途別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のサイバーナイフ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 用途別
  • 最終用途別
  • 国別
• 欧州：国別分析
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋のサイバーナイフ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 用途別
  • 最終用途別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア

第9章 南米のサイバーナイフ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 用途別
  • 最終用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのサイバーナイフ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 用途別
  • 最終用途別
  • 国別
• 中東・アフリカ：国別分析
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品開発
• 最近の動向

第13章 ポーター分析

第14章 PESTEL分析

第15章 競合情勢

• Accuray Incorporated
• Varian Medical Systems Inc.
• Koninklijke Philips N.V.
• Hitachi, Ltd.
• Mevion Medical Systems
• Mitsubishi Heavy Industries, Ltd.
• RaySearch Laboratories
• Siemens Healthineers AG
• ViewRay, Inc.

第16章 戦略的提言

第17章 調査会社・免責事項

Global CyberKnife Market was valued at USD 448.24 million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 17.28% through 2029. The global CyberKnife market revolves around the CyberKnife System, a revolutionary medical technology developed by Accuray Incorporated. This system integrates advanced robotics, real-time imaging, and precise radiation delivery to treat tumors and medical conditions with unparalleled accuracy. Offering a non-invasive alternative to traditional surgery, the CyberKnife System treats tumors and lesions across the body without incisions. Utilizing a highly maneuverable robotic arm, the system delivers high doses of radiation from multiple angles with sub-millimeter precision, sparing healthy tissues. Real-time imaging tracks tumor position and adjusts radiation delivery, even accommodating patient movement during treatment. The market is witnessing growth due to several factors, including the system's effectiveness in treating a wide range of cancers, even in challenging locations.

The non-invasive nature of treatment reduces patient recovery time and enhances quality of life. Ongoing research and development efforts continuously refine the technology and broaden its applications. As CyberKnife technology adoption rises, it revolutionizes cancer treatment with its precision, patient-friendliness, and efficiency. Despite challenges such as high procurement and maintenance costs and the need for specialized healthcare professional training, the global CyberKnife market is advancing. It meets the increasing demand for advanced cancer treatment options prioritizing patient well-being and treatment accuracy.

Key Market Drivers

Precision and Accuracy

Precision and accuracy are fundamental attributes driving the global CyberKnife market. The CyberKnife system's exceptional precision refers to its ability to precisely target and deliver high doses of radiation to specific areas within the body. This is achieved through its advanced robotic arm and real-time imaging capabilities, allowing for sub-millimeter accuracy in tumor or lesion treatment. In the medical field, precision is essential to ensure that the radiation is concentrated solely on the intended target, minimizing damage to surrounding healthy tissues and critical structures. The CyberKnife's capability to adjust treatment in real time, even accounting for patient movement during the procedure, enhances its accuracy, resulting in optimal treatment outcomes. Precision and accuracy offer significant advantages to both patients and healthcare providers. Patients experience reduced side effects, shorter recovery times, and improved quality of life due to minimized damage to healthy tissues. Healthcare providers can confidently treat complex cases, including tumors in challenging or delicate locations, while minimizing the risks associated with conventional surgical interventions. These attributes make the CyberKnife system a preferred option for patients and medical professionals seeking effective treatment with minimal invasiveness. As demand grows for medical technologies that prioritize precision and accuracy, the global CyberKnife market continues to expand, playing a pivotal role in transforming the landscape of cancer treatment and other medical conditions.

Non-Invasive Treatment

Non-invasive treatment is a pivotal aspect driving the global CyberKnife market. The term non-invasive refers to medical procedures that do not require surgical incisions or direct penetration of the body. In the context of the CyberKnife system, non-invasive treatment holds great significance as it offers a groundbreaking alternative to traditional surgical interventions. The CyberKnife system utilizes advanced robotics and real-time imaging to deliver highly precise and focused doses of radiation to targeted areas within the body. This approach eliminates the need for incisions or invasive procedures, making it a patient-friendly treatment option. Patients experience minimal discomfort, reduced recovery times, and a lower risk of complications compared to conventional surgeries. The non-invasive nature of CyberKnife treatment extends its applicability to various medical conditions, including tumors, lesions, and neurological disorders. It provides a treatment avenue for patients who may not be suitable candidates for surgery due to health factors or complex medical situations. As patient preferences shift toward minimally invasive treatment options that prioritize their comfort and well-being, the non-invasive nature of the CyberKnife system becomes a significant driver in the global market. The appeal of effective treatment with minimal disruption to daily life fuels the adoption of CyberKnife technology, positioning it as a transformative force in modern healthcare and contributing to the expansion of the global CyberKnife market.

Advancements in Imaging and Robotics

Advancements in imaging and robotics are key drivers in the global CyberKnife market. These innovations have significantly elevated the precision, effectiveness, and versatility of the CyberKnife system - a cutting-edge medical technology developed by Accuray Incorporated. In the context of imaging, state-of-the-art advancements enable real-time visualization of the treatment area. The integration of advanced imaging techniques, such as cone-beam computed tomography (CBCT), allows for on-the-fly adjustments during treatment sessions. This real-time monitoring ensures that the radiation is accurately targeted even if a patient moves or if there are anatomical changes. The incorporation of robotics in the CyberKnife system has revolutionized its maneuverability. The robotic arm can adjust its position with sub-millimeter precision, providing unprecedented flexibility in directing radiation beams from multiple angles. This capability enhances the treatment's accuracy and widens its applications, making it suitable for treating tumors and lesions in intricate or challenging anatomical locations. Advancements in imaging and robotics converge to enhance patient outcomes, enabling clinicians to precisely deliver radiation doses to target areas while minimizing damage to healthy tissues. This progress has expanded the CyberKnife system's applications beyond cancer treatment, encompassing neurological disorders and other medical conditions. The continuous evolution of imaging and robotics ensures that the CyberKnife system remains at the forefront of modern medical technology, driving the global CyberKnife market by offering patients and healthcare providers an unparalleled solution for accurate, non-invasive, and patient-friendly treatment.

Increasing Prevalence of Cancer

The increasing prevalence of cancer is a significant driver in the global CyberKnife market. As cancer cases continue to rise globally, there is a growing demand for innovative and effective treatment options. The CyberKnife system, with its advanced technology and precision, is uniquely positioned to address this challenge. Cancer remains a leading cause of mortality and morbidity worldwide. The CyberKnife system offers a non-invasive approach to treating various types of cancers, providing patients with a valuable alternative to traditional surgical procedures. Its precision in delivering radiation therapy allows for the targeted destruction of cancerous cells while minimizing damage to surrounding healthy tissues. The rising incidence of complex cases, including tumors located in challenging anatomical areas, underscores the need for advanced treatment solutions like CyberKnife. The system's ability to treat tumors in delicate locations, such as the brain, spine, and lungs, sets it apart as a versatile tool in the fight against cancer. As healthcare systems strive to meet the demand for effective cancer treatment options, the CyberKnife system's capability to offer patient-friendly, non-invasive treatment becomes increasingly important. Its ability to enhance treatment outcomes, reduce side effects, and improve patients' quality of life positions it as a vital component in the global effort to combat the increasing prevalence of cancer.

Key Market Challenges

High Initial Costs

High initial costs are a notable restraining factor in the global CyberKnife market. The acquisition and installation of a CyberKnife system entail substantial upfront financial investments that can pose challenges for healthcare institutions and providers. These costs encompass various components, including the purchase of the CyberKnife technology itself, associated equipment, facility modifications, and training. The initial investment required for a CyberKnife system is significant due to its sophisticated technology, advanced robotics, and integrated imaging capabilities. The system's precision and real-time imaging functionalities contribute to its complex design, which in turn contributes to its elevated price point. Moreover, the need for a specialized treatment vault, radiation shielding, and integration with existing medical infrastructure further contributes to the initial costs. For healthcare institutions with limited budgets, these high upfront expenses can present barriers to adopting the CyberKnife system. Smaller hospitals and medical centers might find it challenging to allocate resources for such a substantial investment, particularly when competing with other healthcare priorities. While the long-term benefits of the CyberKnife system, such as improved patient outcomes, reduced side effects, and efficient treatment options, are well-documented, the initial financial burden can deter some healthcare facilities from considering its implementation. Strategies to address this challenge might include exploring leasing options, partnerships, or collaborative arrangements to share costs, as well as advocating for funding from healthcare authorities or private investments. In conclusion, the high initial costs associated with acquiring and installing a CyberKnife system can present a significant obstacle in the global market. While the technology offers substantial benefits in terms of patient care and treatment efficacy, addressing these financial challenges is essential to ensure broader accessibility and adoption of CyberKnife technology across a range of healthcare settings.

Maintenance and Operational Expenses

Maintenance and operational expenses are significant considerations in the global CyberKnife market. While the initial investment in acquiring and installing a CyberKnife system is substantial, ongoing costs related to maintenance and day-to-day operations are equally important factors that impact the viability and sustainability of this advanced medical technology. Maintenance expenses encompass regular servicing, calibration, and repairs required to ensure the CyberKnife system's optimal performance. The technology's complexity, involving advanced robotics and real-time imaging, demands specialized expertise for upkeep. As the system comprises intricate components, preventive maintenance is essential to minimize downtime and ensure accurate treatment delivery. Operational expenses include personnel training, staffing, and administrative costs associated with running the CyberKnife facility. Skilled personnel are needed to operate, monitor, and maintain the technology effectively. Training and continuous education are essential due to the evolving nature of medical technology and the need to stay updated with the latest advancements. Furthermore, operational costs extend to other resources, such as the electricity required to power the system, software updates, and data storage for treatment plans and patient records. Additionally, regular quality assurance and quality control measures are necessary to ensure that the CyberKnife system consistently delivers precise and accurate treatment. The combination of maintenance and operational expenses can pose financial challenges for healthcare institutions, particularly for smaller facilities with limited budgets. Balancing the costs of maintaining and operating the CyberKnife system with its long-term benefits requires careful financial planning and resource allocation. Addressing maintenance and operational expenses might involve negotiating service contracts with the technology provider, streamlining workflows to optimize staff utilization, and exploring opportunities for cost-sharing through collaborations or partnerships. Overcoming these challenges is crucial to ensuring the sustainable and effective utilization of CyberKnife technology in modern healthcare settings.

Key Market Trends

Personalized Treatment

Personalized treatment is a prominent trend in the global CyberKnife market that emphasizes tailoring medical interventions to the unique characteristics of individual patients. In the context of CyberKnife technology, personalized treatment refers to the customization of treatment plans based on a patient's specific medical condition, anatomical features, tumor characteristics, and overall health status. The precision and adaptability of the CyberKnife system make it well-suited for delivering personalized treatments. Advanced imaging capabilities allow healthcare professionals to create highly detailed and accurate images of the tumor and its surrounding tissues. These images guide the development of treatment plans that precisely target the tumor while sparing healthy tissues, minimizing side effects, and maximizing treatment efficacy. Advanced software and algorithms enable healthcare providers to plan treatments that account for the tumor's size, shape, and location. Dosage and radiation angles are optimized for each patient's unique anatomy. During treatment sessions, the system's real-time imaging and robotic capabilities allow for adjustments in response to any patient movement or changes in tumor position. This adaptability ensures that the radiation is accurately delivered to the intended target. Personalized treatment takes into consideration a patient's overall health, medical history, and potential risk factors. This holistic approach ensures that treatment plans are both effective and safe for each individual.

Integration with Multidisciplinary Care

Integration with multidisciplinary care is a significant trend in the global CyberKnife market that emphasizes collaborative and comprehensive approaches to patient treatment. In this context, integration refers to the seamless coordination of expertise and resources from various medical disciplines to develop holistic treatment plans that address the diverse needs of patients. The complexity of many medical conditions, especially cancer, often requires expertise from multiple specialties such as oncology, radiology, surgery, and pathology. The CyberKnife system's versatility and precision make it an ideal candidate for integration into multidisciplinary care settings. This approach ensures that patients receive the most effective and well-rounded treatment strategies, considering both the disease and the patient's individual circumstances. Different medical experts collaborate to create comprehensive treatment plans that take into account various aspects of the patient's condition. This collaboration fosters an environment where diverse perspectives contribute to better decision-making. Multidisciplinary care allows for the tailoring of treatment plans to suit the unique characteristics of each patient. CyberKnife technology's precision aligns well with this approach, enabling targeted treatments that align with the collective expertise of the team. Integration encourages the sharing of knowledge, experience, and best practices among healthcare professionals from different specialties. This interdisciplinary exchange fosters a learning environment that benefits both patients and providers. The integration of CyberKnife technology into multidisciplinary care settings enhances the quality of patient care by leveraging its precision, adaptability, and ability to treat a wide range of medical conditions. As the trend of patient-centric care continues to grow, the collaboration between specialists and the utilization of advanced technologies like CyberKnife play a pivotal role in ensuring comprehensive and effective treatment strategies for patients.

Segmental Insights

Application Insights

In 2023, the CyberKnife Market was dominated by the cancer segment and is predicted to continue expanding over the coming years. CyberKnife technology's hallmark lies in its unparalleled precision and accuracy, enabling highly targeted radiation therapy. By leveraging cutting-edge imaging and robotic techniques, CyberKnife empowers clinicians to administer radiation with exceptional precision, minimizing harm to surrounding healthy tissues. This precision seamlessly aligns with the evolving paradigm of precision medicine in oncology, where personalized treatments are paramount.

In today's cancer treatment landscape, multimodal therapy has gained prominence for its effectiveness against complex malignancies. CyberKnife seamlessly integrates into this approach, providing a versatile platform that complements other modalities like chemotherapy and surgery. Its capability to deliver precise radiation to tumors, even those considered inoperable or resistant to traditional therapies, positions it as a cornerstone in the multimodal treatment arsenal against cancer.

Over time, CyberKnife technology has expanded to address a broader spectrum of cancer indications, spanning from primary tumors to metastatic lesions and recurrent diseases. This diversification underscores the technology's versatility and effectiveness across various cancer types, enhancing its appeal to both clinicians and patients. Moreover, ongoing research and clinical trials continue to explore novel applications, further cementing its position as a leader in the oncology landscape.

Regional Insights

In 2023, the Global CyberKnife Market was dominated by the North America segment and is predicted to continue expanding over the coming years. The region possesses a strong healthcare infrastructure characterized by a high demand for advanced cancer treatment technologies. CyberKnife, a state-of-the-art robotic radiosurgery system, delivers precise, non-invasive treatment for tumors across the body, particularly beneficial for challenging or intricate cases. This capability resonates with North America's focus on pioneering healthcare solutions, stimulating adoption among healthcare providers and patients. North America hosts numerous leading medical institutions and research centers renowned for their expertise in cancer care. These institutions frequently lead the way in adopting innovative technologies like CyberKnife, contributing significantly to its widespread usage and market dominance. Additionally, the region's commitment to research and development drives ongoing enhancements in CyberKnife technology, ensuring its continued leadership in precision radiation therapy.

Also, favorable reimbursement policies and comprehensive insurance coverage in North America facilitate the uptake of CyberKnife treatment. Patients can access this advanced technology without encountering significant financial obstacles, bolstering its market penetration. Furthermore, the region's sizable patient population, especially those seeking treatment for various cancers, serves as a substantial market base for CyberKnife utilization. North America's regulatory framework promotes innovation and prioritizes patient safety in the integration of technologies like CyberKnife. Rigorous standards and approvals inspire confidence among healthcare providers and patients, further catalyzing market expansion.

Key Market Players

Accuray Incorporated

Varian Medical Systems Inc.

Koninklijke Philips N.V.

Hitachi, Ltd.

Mevion Medical Systems

Mitsubishi Heavy Industries, Ltd.

RaySearch Laboratories

Siemens Healthineers AG

ViewRay, Inc.

Report Scope:

In this report, the Global CyberKnife Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

CyberKnife Market, By Application:

Tumor Cancer Vascular malformation Others

CyberKnife Market, By End Use:

Hospitals Outpatient facilities Research and Manufacturing

CyberKnife Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global CyberKnife Market.

Available Customizations:

Global CyberKnife Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global CyberKnife Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Tumor, Cancer, Vascular malformation, Others)
  • 5.2.2. By End-use (Hospitals, Outpatient facilities, Research and Manufacturing)
  • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.4. By Company (2023)
• 5.3. Product Market Map
  • 5.3.1. By Application
  • 5.3.2. By End Use
  • 5.3.3. By Region

6. North America CyberKnife Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States CyberKnife Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By End Use
  • 6.3.2. Canada CyberKnife Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By End Use
  • 6.3.3. Mexico CyberKnife Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By End Use

7. Europe CyberKnife Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany CyberKnife Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By End Use
  • 7.3.2. France CyberKnife Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom CyberKnife Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy CyberKnife Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain CyberKnife Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By End Use

8. Asia-Pacific CyberKnife Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China CyberKnife Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By End Use
  • 8.3.2. Japan CyberKnife Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By End Use
  • 8.3.3. India CyberKnife Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By End Use
  • 8.3.4. South Korea CyberKnife Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia CyberKnife Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By End Use

9. South America CyberKnife Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil CyberKnife Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina CyberKnife Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia CyberKnife Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By End Use

10. Middle East and Africa CyberKnife Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. UAE CyberKnife Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia CyberKnife Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By End Use
  • 10.3.3. South Africa CyberKnife Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Porter's analysis

14. PESTEL analysis

15. Competitive Landscape

• 15.1. Accuray Incorporated
  • 15.1.1. Business Overview
  • 15.1.2. Product & Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (If Listed)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. Varian Medical Systems Inc.
• 15.3. Koninklijke Philips N.V.
• 15.4. Hitachi, Ltd.
• 15.5. Mevion Medical Systems
• 15.6. Mitsubishi Heavy Industries, Ltd.
• 15.7. RaySearch Laboratories
• 15.8. Siemens Healthineers AG
• 15.9. ViewRay, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer